1. Home
  2. CBAN vs CCCC Comparison

CBAN vs CCCC Comparison

Compare CBAN & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$17.40

Market Cap

282.0M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.54

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAN
CCCC
Founded
1975
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.0M
240.3M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
CBAN
CCCC
Price
$17.40
$2.54
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$8.50
AVG Volume (30 Days)
62.2K
1.7M
Earning Date
01-21-2026
11-06-2025
Dividend Yield
2.63%
N/A
EPS Growth
26.78
N/A
EPS
1.59
N/A
Revenue
$122,550,000.00
$30,108,000.00
Revenue This Year
$20.97
N/A
Revenue Next Year
$25.65
N/A
P/E Ratio
$10.99
N/A
Revenue Growth
12.48
N/A
52 Week Low
$13.99
$1.09
52 Week High
$18.41
$5.10

Technical Indicators

Market Signals
Indicator
CBAN
CCCC
Relative Strength Index (RSI) 61.87 51.47
Support Level $17.00 $2.41
Resistance Level $17.70 $2.84
Average True Range (ATR) 0.36 0.19
MACD 0.09 0.01
Stochastic Oscillator 82.25 49.99

Price Performance

Historical Comparison
CBAN
CCCC

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: